6-Methoxypyrido[3,2-b]pyrazin-3(4H)-one, 95.0%, 1g

Primine, avec analyt. Documents, 20 mg, emballage en verre

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-cyanophenyl)propanoic acid, 97%, 5g

2-Chloro-4-vinylpyrimidine, 97%, 500mg

N-[[(2S)-1-[[5-(4-Fluorophenyl)-2-methyl-4-thiazolyl]carbonyl]-2-piperidinyl]methyl]-4-benzofurancarboxamide, 99%, 100mg

1-Bromo-3-methylbutan-2-one, 95.0%, 10g

2-(7-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-oxo-2H-chromen-4-yl)acetic acid, 95%, 100mg

4-(4-Chlorophenoxy)-3-fluorobenzonitrile, 95%, 1g

N-[3-oxo-3-[[(1R)-1,2,3,4-tetrahydro-1-naphthalenyl]amino]propyl]-4-(trifluoromethoxy)-benzamide, 250mg

tert-butyl 2-methyl-3-[(pentan-2-yl)amino]propanoate, 95.0%, 2g

4-Bromo-2-hydroxyphenylboronic acid, 98+%, 100mg

1-Bromo-3-methoxypropane, 98.0%, 25g

Dichlorobis(dicyclohexylphenylphosphine)nickel(II)>95.0%(T)250mg